- AFTERMARKET PERFORMANCE. // Investment Dealers' Digest;2/19/2007, Vol. 73 Issue 7, p27
Several charts depicting data related to the IPO performances of various companies including Omrix Biopharmaceuticals Inc., Fortress Investment Group LLC and Mellanox Technologies Inc. are presented.
- AFTERMARKET PERFORMANCE. // Investment Dealers' Digest;3/12/2007, Vol. 73 Issue 10, p27
Several charts are presented that list initial public offerings by various companies in the U.S. including Omrix Biopharmaceuticals, Vonage Holdings, and Restore Medical.
- AFTER PERFORMANCE. // Investment Dealers' Digest;4/9/2007, Vol. 73 Issue 14, p39
Several charts on the performance of Initial Public Offerings and stock offerings of several companies during 2007, including Omrix Biopharmaceuticals Inc., New Oriental Education, and Glu Mobile Inc. are presented.
- AFTERMARKET PERFORMANCE. // Investment Dealers' Digest;12/11/2006, Vol. 72 Issue 47, p23
Several charts are presented that lists aftermarket performance of initial public offering on securities in the U.S. including Riverbed Technology Inc., North American Energy and Copano Energy LLC.
- PRICE IS WRONG FOR 2006 IPOs. // Crain's New York Business;6/5/2006, Vol. 22 Issue 23, p3
The article reports that shares in the eight New York area companies that have completed initial public offerings so far in 2006 have fared poorly in the volatile market. The firms' stocks have fallen an average of 6.6% and only three of them have posted gains. The firms which have posted gains...
- AFTERMARKET PERFORMANCE. // Investment Dealers' Digest;4/16/2007, Vol. 73 Issue 15, p27
Several charts are presented that list the financial performance of aftermarkets including Omrix Biopharmaceuticals Inc., Vonage Holdings Corp., and Veraz Networks Inc.
- SECURITIES IN REGISTRATION: EQUITY. // Investment Dealers' Digest;1/23/2006, Vol. 72 Issue 3, p54
A list of the planned new offerings that have been registered with the U.S. Securities and Exchange Commission in the past one month is presented. They are as follows: Acadia Pharmaceuticals Inc., Cardium Therapeutics, Cliff Rock Resources, Human Biosystems and Omrix Biopharmaceuticals Inc.
- Win Some, Lose Some. Fitzgibbon Jr., John E. // Red Herring;4/16/2007, Vol. 4 Issue 14, p36
The article discusses the performance of the U.S. initial public offering (IPO) market in the year 2006-2007. According to the U.S. Securities and Exchange Commission reports, from April 1,2006, through March 30, 2007, bankers priced 202 IPOs and the average gain for all 202 IPOs was 25.8%....
- MasterCard IPO Has a Big Upside. Grover, Eric // Cards & Payments;Feb2006, Vol. 19 Issue 2, p48
No abstract available.